Your browser doesn't support javascript.
loading
Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection.
Gaebler, Christian; DaSilva, Justin; Bednarski, Eva; Muecksch, Frauke; Schmidt, Fabian; Weisblum, Yiska; Millard, Katrina G; Turroja, Martina; Cho, Alice; Wang, Zijun; Caskey, Marina; Nussenzweig, Michel C; Bieniasz, Paul D; Hatziioannou, Theodora.
Afiliação
  • Gaebler C; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.
  • DaSilva J; Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.
  • Bednarski E; Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.
  • Muecksch F; Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.
  • Schmidt F; Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.
  • Weisblum Y; Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.
  • Millard KG; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.
  • Turroja M; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.
  • Cho A; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.
  • Wang Z; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.
  • Caskey M; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.
  • Nussenzweig MC; Laboratory of Molecular Immunology, The Rockefeller University, New York, New York, USA.
  • Bieniasz PD; Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.
  • Hatziioannou T; Laboratory of Retrovirology, The Rockefeller University, New York, New York, USA.
Open Forum Infect Dis ; 9(7): ofac227, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35818364
The emergence of severe acute respiratory syndrome coronavirus 2 variants that have greater transmissibility and resistance to neutralizing antibodies has increased the incidence of breakthrough infections. We show that breakthrough infection increases neutralizing antibody titers to varying degrees depending on the nature of the breakthrough variant and the number of vaccine doses previously administered. Omicron breakthrough infection resulted in neutralizing antibody titers that were the highest across all groups, particularly against Omicron.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos